Search Results
Aug 28, 2026, 14:28 ET AtaiBeckley Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AtaiBeckley Inc. - ATAI
AtaiBeckley Inc. (NasdaqGM: ATAI) to Eli Lilly and Company (NYSE: LLY). Under the terms of the proposed transaction, shareholders of AtaiBeckley will receive $6.75 per share in cash,
More news about: Kahn Swick & Foti, LLC
Aug 17, 2026, 21:16 ET Are DSGR, HLX, ATAI, CRNX Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-dsgr-hlx-atai-crnx-obtaining-fair-deals-for-their-shareholders-302853324.htmlSOURCE
More news about: Halper Sadeh LLP
Aug 06, 2026, 11:00 ET SolidRun and Leopard Imaging Collaborate to Accelerate Edge AI Vision Development
transition from prototype to production."Our mission has always been to simplify the development of advanced embedded AI systems," said Dr. Atai Ziv, CEO of
More news about: SolidRun
Aug 04, 2026, 12:53 ET Are SOLS, LXP, ATAI Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-sols-lxp-atai-obtaining-fair-deals-for-their-shareholders-302842737.htmlSOURCE
More news about: Halper Sadeh LLP
Jul 21, 2026, 14:50 ET Are PSNL, LXP, DSGR, ATAI Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-psnl-lxp-dsgr-atai-obtaining-fair-deals-for-their-shareholders-302831083.htmlSOURCE
More news about: Halper Sadeh LLP
Jul 21, 2026, 08:30 ET Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates
developments include: Helus PharmaTM (NASDAQ: HELP) (Cboe CA: HELP), Eli Lilly and Company (NYSE: LLY), AtaiBeckley Inc. (NASDAQ: ATAI), Compass Pathways plc (NASDAQ: CMPS), Johnson & Johnson (NYSE: JNJ).
More news about: Market News Updates
Jul 17, 2026, 08:50 ET Big Pharma Just Paid Up to $3.8 Billion for Psychedelic Medicine, and the Rest of the Sector Is Being Repriced in Real Time
for fiscal 2027. The stock gained about 6% on the deal.AtaiBeckley Inc. (NASDAQ: ATAI) is included because it is now the sector's benchmark, not despite it. Formed by the combination of atai Life Sciences and Beckley Psytech, its shares had gained roughly 31% year to date against a $1.97
More news about: USA News Group
Jul 16, 2026, 18:17 ET Are ATAI, FHB, PATK Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-atai-fhb-patk-obtaining-fair-deals-for-their-shareholders-302828029.htmlSOURCE
More news about: Halper Sadeh LLP
Jul 16, 2026, 14:23 ET $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of AtaiBeckley Inc. (NASDAQ: ATAI)
ATAI) related to its sale to Eli Lilly and Company. Under the terms of the proposed transaction, AtaiBeckley shareholders are expected to receive
More news about: Monteverde & Associates PC
Jul 16, 2026, 12:03 ET Shareholder Alert: Ademi LLP investigates whether AtaiBeckley Inc. is obtaining a Fair Price for Public Shareholders
MILWAUKEE, July 16, 2026 /PRNewswire/ -- Ademi LLP is investigating AtaiBeckley (Nasdaq: ATAI) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Eli Lilly.
More news about: Ademi LLP
Jul 16, 2026, 06:45 ET Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions
NEW YORK, July 16, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and AtaiBeckley Inc. (Nasdaq: ATAI), a clinical-stage biopharmaceutical company developing innovative therapeutics for mental health conditions, today announced a definitive agreement
More news about: Eli Lilly and Company
Jun 29, 2026, 07:00 ET OpenBox AI Partners with CopilotKit to Bring Enterprise-Grade Trust to Agentic AI
they want to build on. Using CopilotKit and OpenBox together is the key for creating production-ready agents."— Atai Barkai, Co-founder & CEO, CopilotKitAvailabilityThe OpenBox governance integration for the AG-UI stack is available to
More news about: OpenBox AI
Jun 09, 2026, 10:01 ET Alcohol-associated Liver Disease Market Gearing Up for Outstanding Expansion at a CAGR of 31.1% During the Forecast Period (2026-2036) | DelveInsight
epidemiology, as well as the market trends, market drivers, market barriers, and key AUD companies, including Adial Pharmaceuticals, Beckley Psytech and Atai Life Sciences, MediciNova, Imbrium Therapeutics (subsidiary of Purdue Pharma), Tempero Bio, Nxera Pharma, Altimmune, Alkermes, Lundbeck, Otsuka Pharmaceuticals,
More news about: DelveInsight Business Research, LLP
Jun 04, 2026, 08:30 ET SolidRun and Peridio Accelerate Development of Physical AI Deployments by Adding Avocado OS to RZ/V2N Vision AI Platforms
proven path from prototype to production fleet, backed by the hardware performance and reliability they need for demanding vision AI workloads," said Dr. Atai Ziv, CEO of SolidRun.Avocado OS: Production-Grade Linux Built for Physical AI FleetsPeridio's Avocado OS is a purpose-built,
More news about: SolidRun
May 28, 2026, 08:15 ET Psilera Closes Oversubscribed $8.8M Seed Funding Round to Accelerate Neuroplastogen PSIL-006 Into the Clinic
of up to $2 million for IND-enabling studies of PSIL-006 in alcohol use disorder (AUD)Execution of a strategic licensing agreement with atai Life Sciences (now AtaiBeckley) for its
More news about: Psilera, Inc.
Mar 09, 2026, 10:50 ET CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions
translate that momentum into approved treatments: Helus Pharma (NASDAQ: HELP), Compass Pathways (NASDAQ: CMPS), AtaiBeckley (NASDAQ: ATAI), Definium Therapeutics (NASDAQ: DFTX), and GH Research (NASDAQ: GHRS).
More news about: USA News Group
Mar 09, 2026, 08:30 ET SolidRun Unveils Next-Gen COM Express Type 6 Modules for Rugged Edge AI Systems
mobile platforms, harsh industrial sites, and mission-critical deployments where serviceability, and longevity matter as much as raw compute," said Dr. Atai Ziv, CEO of SolidRun. "Our new P100 COM Express Type 6 modules are built to deliver powerful AI performance at the edge while improving the mechanical
More news about: SolidRun
Feb 27, 2026, 11:44 ET Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments
candidates[2]. Five companies are building the clinical programs to get there: Helus Pharma (NASDAQ: HELP), AtaiBeckley (NASDAQ: ATAI), Definium Therapeutics (NASDAQ: DFTX), GH Research (NASDAQ: GHRS), and LB Pharmaceuticals (NASDAQ: LBRX).
More news about: Equity Insider
Jan 08, 2026, 08:15 ET Distinguished Neuroscience Expert Magali Haas, MD/PhD, Joins Psilera as Chief Medical Officer
patients affected by debilitating brain disorders."Building on strong momentum in 2025, including the successful IP licensing agreement with atai Life Sciences (now
More news about: Psilera, Inc.
Nov 20, 2025, 17:31 ET Alcohol Use Disorder Market to Grow Rapidly at a 13.6% CAGR by 2034 Owing to Rising Disease Prevalence, Significant Advancements in Genetically-targeted Therapies, along with Innovative Treatments such as GLP-1 Receptor Agonists | DelveInsight
condition.Leading AUD companies developing emerging therapies, such as Adial Pharmaceuticals (AD04), Beckley Psytech and Atai Life Sciences (BPL-003), MediciNova (Ibudilast), Imbrium Therapeutics (subsidiary of Purdue Pharma) (Sunobinop), Tempero
More news about: DelveInsight Business Research, LLP
Nov 12, 2025, 10:34 ET National Security Leader Stu Shea Joins Partsol's Board of Strategic Advisors
Security Shea's appointment comes as Partsol expands deployment of its flagship Cognitive AI platforms, Atai and Checkmate, across defense and intelligence operations. These platforms are powered by Partsol's AI Stem Cell technology, enabling systems like Checkmate
More news about: Partsol
Nov 06, 2025, 11:43 ET Partsol Defense Secures U.S. Department of War Contract for Checkmate: The AI Stem Cell-Powered Platform Protecting America's Critical Supply Chains
Under this agreement, the DOW will utilize Atai Cognitive AI for rapid, deep due diligence, a capability essential for validating the trustworthiness and accuracy of defense vendors and contractors. Atai remains the only AI platform capable of delivering hallucination-free,
More news about: Partsol
Oct 29, 2025, 08:30 ET Miami Biotech Collective Introduces Board of Advisors and Women's Leadership Council to Shape South Florida's Biotech Future
former CEO of Marinus Therapeutics, has over 30 years in biotech and pharma, spanning clinical practice, investment leadership, and board service at atai Life Sciences, RAPT Therapeutics and Caribou Biosciences.
More news about: Miami Biotech Collective
Oct 16, 2025, 05:00 ET Peptilogics Raises $78 Million to Advance Zaloganan Into Pivotal Trial
commitment to advancing transformative technologies. These investors have backed paradigm-shifting companies including AbCellera (ABCL), Atai Life Sciences (ATAI), New Amsterdam Pharma (NAMS), Compass Pathways (CMPS), Kriya Therapeutics, and F2G. This group combines deep domain expertise with a shared
More news about: Peptilogics